FDA Inspection 1293102 - Apertus Pharmaceuticals - October 31, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Apertus Pharmaceuticals, with an inspection on October 31, 2025, issued by the Kansas City District Office, covering human drugs.

Company: Apertus Pharmaceuticals
Inspection Date: October 31, 2025
Product Type: Human Drugs
Office: Kansas City District Office

Open in Dashboard

ID · d2159b71-ad5c-474a-a568-a403b00cb157